CAS
AVNS

Coppell Advisory Solutions’s Avanos Medical AVNS Stock Holding History

Coppell Advisory Solutions’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6
Closed -$93 – 446
2024
Q4 		$93 Hold
6
– – ﹤0.01% 1901
2024
Q3 		$143 Hold
6
– – ﹤0.01% 1761
2024
Q2 		$120 Buy
+6
New +$117 ﹤0.01% 1697

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coppell Advisory Solutions's AVNS Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 6 shares — an estimated $93 sold.

Coppell Advisory Solutions first reported a position in AVNS in Q2 2024 and held it in 3 quarters. The position peaked at $143 in Q3 2024. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 6 Avanos Medical shares in Q1 2025, an estimated $93.
  • Coppell Advisory Solutions first reported a position in Avanos Medical in Q2 2024 and held it in 3 quarters.
  • Coppell Advisory Solutions's Avanos Medical position peaked at $143 in Q3 2024.
  • 277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.